1.
Wirk B, Lim J. Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma. J Hematol [Internet]. 2025 Apr. 22 [cited 2025 Apr. 25];. Available from: https://jh.elmerpub.com/jh/article/view/2046